Kyungpook National University Hospital
About Kyungpook National University Hospital
Kyungpook National University Hospital is a national university hospital located in 130 Dongdeok-ro, Jung-gu, Daegu City, South Korea. The first Western medicine was introduced to Daegu city in 1897, at Widespread Relief House.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kyungpook National University Hospital
36
Pfizer
21
Hoffmann-La Roche
15
Takeda
14
Gilead Sciences
12
Celgene
9
Janssen Research & Development, LLC
9
Seung-Jung Park
9
Asan Medical Center
6
Boryung Pharmaceutical Co., Ltd
6
Eli Lilly and Company
6
Clinical Trials at Kyungpook National University Hospital
During the past decade, Kyungpook National University Hospital conducted 199 clinical trials. In the 10-year time frame, 199 clinical trials started and 74 clinical trials were completed, i.e. on
average, 37.2% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 47 clinical trials were completed. i.e. 73.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
2006-05-31
2008-12-31
Completed
199
Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
2006-09-01
2008-08-01
Completed
191
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
2007-02-01
2008-10-01
Completed
933
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
2006-10-01
2009-01-01
Completed
2,645
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
2007-10-01
2010-04-01
Completed
1,175
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
2008-05-01
2016-08-01
Completed
701
Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder
2008-07-01
2008-12-01
Terminated
24
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kyungpook National University Hospital" #1 sponsor was "Kyungpook National University Hospital" with 36 trials, followed by "Pfizer" with 21 trials
sponsored, "Hoffmann-La Roche" with 15 trials sponsored, "Takeda" with 14 trials sponsored and "Gilead Sciences"
with 14 trials sponsored. Other sponsors include 193 different institutions and
companies that sponsored additional 104 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kyungpook National University Hospital"
#1 collaborator was "Kyungpook National University Hospital" with 16 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Pusan National University Hospital" with 5 trials as a collaborator and "Chonnam National University Hospital" with 4 trials as a collaborator. Other collaborators include 171 different institutions and companies that were
collaborators in the rest 127 trials.
Clinical Trials Conditions at Kyungpook National University Hospital
According to Clinical.Site data, the most researched conditions in "Kyungpook National University Hospital" are
"Crohn's Disease" (13 trials), "Coronary Artery Disease" (10 trials), "Gastric Cancer" (9 trials), "Ulcerative Colitis" (9 trials) and "Breast Cancer" (8 trials). Many other conditions were trialed in "Kyungpook National University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kyungpook National University Hospital
Most popular intervention types in "Kyungpook National University Hospital" are "Drug" (220 trials), "Other" (23 trials), "Biological" (22 trials), "Device" (21 trials) and "Procedure" (21 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (59 trials), "Dexamethasone" (7 trials), "Capecitabine" (6 trials), "Atezolizumab" (5 trials) and "Lansoprazole" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Kyungpook National University Hospital
The vast majority of trials in "Kyungpook National University Hospital" are
280 trials for "All" genders, 11 trials for "Male" genders and 4 trials for "Female" genders.
Clinical Trials Status at Kyungpook National University Hospital
Currently, there are NaN active trials in "Kyungpook National University Hospital".
undefined are not yet recruiting,
57 are recruiting,
42 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 146 completed trials in Kyungpook National University Hospital,
undefined suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Kyungpook National University Hospital, 25 "Phase 1"
clinical trials were conducted, 53 "Phase 2" clinical
trials and 121 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 38 trials, and there were
also 33 trials that are defined as “Not Applicable".